Get your Pfizer COVID-19 vaccine. Walk-ins welcome! Mon., Wed., Fri.: 8 a.m. - 5 p.m. and Tues., Thurs.: 8 a.m. - 7 p.m. >

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating Efficacy and Safety of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis

Investigator: Sheetal Shroff, MD

Study Coordinator:

Status: Enrolling

ClinicalTrials.gov Number: NCT03971422

Phone:

Protocol Number: Pro00022515

Description

The purpose of the MycarinGstudy is to demonstrate the clinical efficacy and to assess safety and tolerability of rozanolixizumab in patients with generalized myasthenia gravis (MG). NCT number: NCT03971422
More to Explore
Search Clinical Trials
Join a Clinical Trial
Clinical Research Support Services for Investigators
Weill Cornell Medical College Clinical Trials